Multi-site Communication Deficits in Schizophrenia (NCT01317121) | Clinical Trial Compass
CompletedNot Applicable
Multi-site Communication Deficits in Schizophrenia
Germany90 participantsStarted 2011-07
Plain-language summary
Multi-site Communication Deficits Underlying Cognitive Dysfunction in the Prodromal Phase and First Episode of Schizophrenia
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria schizophrenic patients:
* Signed written informed consent.
* Inpatients of the Clinic for Psychiatry and Psychotherapy of the University Hospital Hamburg-Eppendorf (UKE), Hamburg, Germany.
* Diagnosis of schizophrenia according to ICD-10 and DSM-IV criteria.
Exclusion criteria schizophrenic patients:
* Epilepsy or other disorders of the nervous system, further psychiatric or neurological disorders.
* Suicidal tendencies.
* Acute or lifetime alcohol abuse.
* Hearing impairment.
* Intelligence quotient (IQ) below average.
* Non-magnetoencephalography(MEG)/ magnetic resonance imaging(MRI) compatible metallic implants.
Inclusion criteria subjects at risk:
* Signed written informed consent.
* Outpatients of the early diagnosis center of the University Department of Psychiatry at the University Hospital Hamburg-Eppendorf (UKE)Germany.
* Meeting high risk criteria for schizophrenia according to the Structured Interview for Prodromal Syndromes (SIPS).
Exclusion criteria subjects at risk:
* Epilepsy or other disorders of the nervous system, further psychiatric or neurological disorders.
* Suicidal tendencies.
* Acute or lifetime alcohol abuse.
* Hearing impairment.
* IQ below average.
* Non-MEG/MRI compatible metallic implants.
Inclusion criteria healthy controls:
* Signed written informed consent.
* Healthy male and female subjects recruited from students and hospital staff of the University Hospital Hamburg-Eppendorf (UKE), Hamburg, Germany.
Exclusion cr…
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.